SEARCH
= Paid-up subscribersSavill P. Triple antiplatelet therapy no better than standard regimens after ischaemic stroke. Practitioner Jan 2018;262(1811):8-9
Triple antiplatelet therapy no better than standard regimens after ischaemic stroke
23 Jan 2018
Intensive antiplatelet therapy with three agents did not reduce the incidence and severity of recurrent stroke or transient ischaemic attack (TIA) but did significantly increase the risk of major bleeding in the TARDIS study.
This article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.